Home › Funds › Addis & Hill, Inc › NMRA
Addis & Hill, Inc position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Addis & Hill, Inc reported holding 163,386 shares of NMRA (NEUMORA THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$278K, representing 0.15% of its reported portfolio and ranking #28 among its reported holdings. Addis & Hill, Inc has disclosed NMRA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-10-19 · Source: SEC EDGAR Form 13F-HR
How Addis & Hill, Inc's NMRA position evolved
Addis & Hill, Inc first disclosed a stake in NMRA in Q1 2024 at 314,821 shares (US$4.2M). Across 11 filings, Addis & Hill, Inc increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 163,386 shares valued at US$278K. Notable position changes include a 46% trim in Q4 2024 (shares fell 91% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 314.82K | $4.19M | New |
| Q2 2024 | 300.00K | $2.94M | Reduce |
| Q3 2024 | 300.00K | $3.96M | Hold |
| Q4 2024 | 163.39K | $1.73M | Reduce |
| Q1 2025 | 163.39K | $163.39K | Hold |
| Q2 2025 | 163.39K | $119.81K | Hold |
| Q3 2025 | 163.39K | $290.83K | Hold |
| Q4 2025 | 163.39K | $292.46K | Hold |
| Q1 2026 | 163.39K | $318.60K | Hold |
| Q2 2026 | 163.39K | $277.76K | Hold |
| Q3 2026 | 163.39K | $277.76K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NMRA and 13F data
NMRA (NEUMORA THERAPEUTICS INC.) is a Health Care company. 23 other funds we track also report a position in NMRA — the largest reported positions include SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NMRA
- SOFTBANK GROUP CORP. 6.09M sh · $10.35M · Q2 2026
- MIC Capital Management UK LLP 4.46M sh · $7.58M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 3.31M sh · $5.63M · Q2 2026
- ICONIQ Capital, LLC 2.56M sh · $4.35M · Q2 2026
- Lunate Capital Ltd 2.12M sh · $3.61M · Q2 2026
- Boxer Capital Management, LLC 2.00M sh · $3.40M · Q2 2026
- JOHNSON & JOHNSON 1.85M sh · $3.14M · Q2 2026
More on Addis & Hill, Inc
FAQ
How long has Addis & Hill, Inc held NMRA?
Addis & Hill, Inc has disclosed NMRA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Addis & Hill, Inc's current position in NMRA?
As of Q3 2026, Addis & Hill, Inc holds 163.39K shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $277.76K, representing 0.15% of its reported portfolio and ranking #28.
Has Addis & Hill, Inc been buying or selling NMRA?
In the latest 13F filing (Q3 2026), Addis & Hill, Inc held unchanged its position in NMRA.
Which other funds hold NMRA?
Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.